Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia
Thrombosis and Haemostasis · 01.03.2024 · 124 (03) · 253-262
DOI: 10.1055/a-2184-7506 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.03.2024. Verfasst von Chuan-Tsai Tsai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Atrial Fibrillation, Alzheimer Disease, Dementia, Vascular, Stroke. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taipei Veterans General Hospital, Research Foundation of Cardiovascular Medicine, Taipei, Taiwan.
Themen: Demenz
Abstract (Originalsprache)
Background
Dementia and atrial fibrillation (AF) have many shared risk factors. Besides, patients with dementia are under-represented in randomized trials, and even if AF is present, oral anticoagulants (OACs) are not prescribed frequently. This study aimed to report the incidence of newly diagnosed AF in dementia patients, and the impacts of use of vitamin K antagonist (VKA; e.g., warfarin) and non-VKA OAC (NOACs) on stroke and bleeding outcomes.
Methods
Our study utilized the Taiwan National Health Insurance Research Database. A total of 554,074 patients with dementia were compared with 554,074 age- and sex-matched patients without dementia regarding the risk of incident AF. Among patients with dementia who experienced incident AF, the risks of clinical events of patients treated with warfarin or NOACs were compared with those without OACs (reference group).
Results
The risk of incident AF was greater for patients with dementia compared with those without (adjusted hazard ratio [aHR]: 1.054; 95% confidence interval [CI]: 1.040–1.068 for all types of dementia, aHR: 1.035; 95% CI: 1.020–1.051 for presenile/senile dementia, and aHR: 1.125; 95% CI: 1.091–1.159 for vascular dementia). Among patients with dementia and experienced incident AF, warfarin use was associated with a higher risk of ischemic stroke (aHR: 1.290; 95% CI: 1.156–1.440), intracranial hemorrhage (ICH; aHR: 1.678; 95% CI: 1.346–2.090), and major bleeding (aHR: 1.192; 95% CI: 1.073–1.323) compared with non-OACs. NOAC use was associated with a lower risk of ischemic stroke (aHR: 0.421; 95% CI: 0.352–0.503) and composite risk of ischemic stroke or major bleeding (aHR: 0.544; 95% CI: 0.487–0.608) compared with non-OACs. These results were consistent among the patients after the propensity matching.
Conclusion
In this large nationwide cohort, the risk of newly diagnosed AF was higher in patients with dementia (all dementia, presenile/senile dementia, and vascular dementia) compared with those without dementia. For patients with dementia who experienced incident AF, NOAC use was associated with a better clinical outcome compared with non-OAC. Patients with dementia require a holistic approach to their care and management, including the use of NOACs to reduce the risks of clinical events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
- Institute of Clinical Medicine and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- The Cardiovascular Department, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.
- College of Medicine, Chang Gung University, Taoyuan, Taiwan.
- Microscopy Core Laboratory, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.
- Department of Family Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Förderung
- Ministry of Science and Technology
- Taipei Veterans General Hospital
- Research Foundation of Cardiovascular Medicine, Taipei, Taiwan
- Szu-Yuan Research Foundation of Internal Medicine, Taipei, Taiwan
Zitieren
APA
Tsai, C. T., Chan, Y. H., Liao, J. N., Chen, T. J., Lip, G. Y. H., Chen, S. A., & Chao, T. F. (2024). Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia. Thrombosis and Haemostasis, 124(03), 253-262. https://doi.org/10.1055/a-2184-7506
Vancouver
Tsai CT, Chan YH, Liao JN, Chen TJ, Lip GYH, Chen SA, et al. Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia. Thrombosis and Haemostasis. 2024;124(03):253-262. doi:10.1055/a-2184-7506
BibTeX
@article{Tsai2024,
author = {Tsai, Chuan-Tsai and Chan, Yi-Hsin and Liao, Jo-Nan and Chen, Tzeng-Ji and Lip, Gregory Y H and Chen, Shih-Ann and Chao, Tze-Fan},
title = {Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia},
journal = {Thrombosis and Haemostasis},
year = {2024},
volume = {124},
number = {03},
pages = {253--262},
doi = {10.1055/a-2184-7506}
}
EUVIMED